Biosimilar Drugs Webinar

Tuesday, December 13, 2016
2:00 – 3:00 pm Central

Learning Objective

This webinar will provide an overview of the legislative and regulatory framework surrounding biosimilar drugs as well as present current issues for consideration including interchangeability, naming/labeling, implementation, and reimbursement.

Speakers

Phil Johnson, MS RPh FHOPA FASHP
Moffitt Cancer Center, Director of Pharmacy (Retired)
Premier Inc., Oncology Director (Retired)

Edward Li, PharmD MPH BCOP
Associate Professor
University of New England College of Pharmacy

Ali McBride, PharmD MS BCPS
Clinical Coordinator
The University of Arizona Cancer Center - The University of Arizona

Target Audience

This free event is open to HOPA members and non-members.

Registration Information

Registration is limited to 100 attendees. To secure your spot follow the registration link below.

https://www.surveymonkey.com/r/SJVQM2P